Insulet Corporation’s PODD rapid commercial expansion and increasing market access capabilities for its Omnipod platform are poised to help it grow in the upcoming quarters. The rising adoption ...
Insulet (PODD) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.40 per share a year ago. These figures ...
Investors eyeing a purchase of Insulet Corp (Symbol: PODD) stock, but cautious about paying the going market price of $285.98/share, might benefit from considering selling puts among the ...
Click here to discover the nuances of Insulet with our detailed analytical report. NasdaqGS:PODD Revenue & Expenses Breakdown as at Mar 2025 Insulet (NasdaqGS:PODD) has rewarded its shareholders ...
Shares of Insulet Co. (NASDAQ:PODD – Get Free Report) have received an average rating of “Moderate Buy” from the seventeen research firms that are currently covering the company, MarketBeat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results